Literature DB >> 3342285

Dose-dependent pharmacokinetics of probenecid in the rat.

B M Emanuelsson1, L K Paalzow.   

Abstract

The basic pharmacokinetics of probenecid was studied by administration of three different i.v. bolus doses (50, 75, and 100 mg kg-1) to rats. The protein binding of probenecid in pooled rat serum was estimated by equilibrium dialysis. The unbound fraction was found to increase non-linearly with increasing total concentration, yielding a maximum free fraction of 49 per cent. The plasma concentration data obtained were described by a two-compartment model with Michaelis-Menten elimination. The maximal rate of elimination (Vm) remained unchanged between different doses irrespective of whether it was calculated in total or free concentrations (mean 187.2 +/- 8.3 (SD) microgram min-1). The Michaelis-Menten constant (Km) decreased slightly with increasing dose, while the unbound Michaelis-Menten constant (Km,u) did not change between the doses (mean 37.1 +/- 1.3 (SD) microgram ml-1). The volume of distribution of the central compartment (Vc) did not alter when the dose was increased from 50 to 100 mg kg-1 (mean 56.5 +/- 4.3 (SD) ml), but the unbound volume of distribution of the central compartment (Vc,u) decreased from 186.5 +/- 15.6 (SD) to 89.8 +/- 6.9 (SD) ml, which is in accordance with the reduction to be expected for drugs that only distribute in the extracellular fluid.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342285     DOI: 10.1002/bod.2510090107

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  9 in total

1.  Potential gamma-hydroxybutyric acid (GHB) drug interactions through blood-brain barrier transport inhibition: a pharmacokinetic simulation-based evaluation.

Authors:  Indranil Bhattacharya; Kathleen M K Boje
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-08-29       Impact factor: 2.745

2.  Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models.

Authors:  H Sun; D W Miller; W F Elmquist
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

3.  Sulfate homeostasis. IV. Probenecid-induced alterations of inorganic sulfate in rats.

Authors:  I M Darling; M E Morris
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

4.  Effect of Efflux Transporter Inhibition on the Distribution of Fluconazole in the Rat Brain.

Authors:  Wei Wang; Na Zheng; Jiatang Zhang; Xusheng Huang; Shengyuan Yu
Journal:  Neurochem Res       Date:  2017-03-24       Impact factor: 3.996

5.  Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans.

Authors:  T B Vree; E W Beneken Kolmer
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

6.  Evaluation of "true" creatinine clearance in rats reveals extensive renal secretion.

Authors:  I M Darling; M E Morris
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

7.  Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

8.  Determination of carrier-mediated transport of 2',3'-dideoxypurine nucleosides in the rat ileum using a bidirectional perfusion technique.

Authors:  R Tyler DeGraw; Bradley D Anderson
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

9.  Probenecid Pre-treatment Downregulates the Kidney Cl-/HCO3- Exchanger (Pendrin) and Potentiates Hydrochlorothiazide-Induced Diuresis.

Authors:  Sharon Barone; Jie Xu; Kamyar Zahedi; Marybeth Brooks; Manoocher Soleimani
Journal:  Front Physiol       Date:  2018-07-11       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.